GlassScriptPhysician profile
Guy T Foster
NPI 1871674861
$16,212.04
in general payments reported to CMS, 2019-2025
51 companies · $2,444 in 2025
The $2,444 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,205 · 2020: $1,886 · 2021: $2,429 · 2022: $2,713 · 2023: $2,180 · 2024: $2,356 · 2025: $2,444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,879 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,879.46 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,353.29 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,841.73 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,660.21 | 2019-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $1,370.30 | 2019-2025 | Dupixent |
| Genzyme Corporation | $1,133.15 | 2019-2025 | |
| Mylan Specialty L.P. | $959.63 | 2019-2024 | Yupelri |
| United Therapeutics Corporation | $542.93 | 2019-2025 | Tyvaso, Tyvaso |
| Baxter Healthcare | $457.51 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Insmed, INC. | $428.66 | 2019-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $407.60 | 2019-2023 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $404.55 | 2020-2025 | Glassia |
| Harmony Biosciences LLC | $402.61 | 2020-2025 | Wakix |
| Pfizer INC. | $273.41 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $268.49 | 2019-2024 | Opsumit, Uptravi |
| Axsome Therapeutics, INC. | $237.86 | 2023-2025 | Sunosi |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.